UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 94

Sortiert nach

Development and implementation of an immunotherapy unit in a urology department

Actas urológicas españolas (English ed.), 2023-01, Vol.47 (1), p.56-63

2023

Volltextzugriff (PDF)

Real World Data Analysis of Type 2 Diabetes Mellitus Treatment In An Integrated Health District

Value in health, 2017-10, Vol.20 (9), p.A478

2017

Volltextzugriff (PDF)

Textbook Outcome in Oncological Pancreatic Surgery. Systematic Review of the Literature

HPB (Oxford, England), 2023, Vol.25, p.S490-S491

2023

Volltextzugriff (PDF)

EPIDEMIOLOGY OF HYPERTENSION IN AN URBAN AREA DEPENDING OF A TERTIARY HOSPITAL

Journal of hypertension, 2018-06, Vol.36 (Supplement 1), p.e242

2018

Volltextzugriff (PDF)

IMPACT ON MORTALITY OF THE GAP IN THE USE OF CARDIOVASCULAR PREVENTING DRUGS IN DIABETES: A POPULATION STUDY

Journal of hypertension, 2018-06, Vol.36 Suppl 1 - ESH 2018 Abstract Book (Supplement 1), p.e10-e10

2018

Volltextzugriff (PDF)

[LB.03.12] THE USE OF CARDIOVASCULAR PREVENTION DRUGS IN SUBJECTS AFTER STROKE OR TIA. A POPULATION STUDY

Journal of hypertension, 2017-09, Vol.35 Suppl 2 - ESH 2017 Abstract Book (Supplement 2), p.e80-e80

2017

Volltextzugriff (PDF)

Desarrollo e implementación de una unidad de inmunoterapia en un servicio de urología

Actas urologicas españolas, 2023-01, Vol.47 (1), p.56-63

2023

Volltextzugriff (PDF)

Niveles de complejidad asistencial en pacientes con códigos diagnósticos de insuficiencia cardiaca en una población

Revista española de cardiologia, 2018-08, Vol.71 (8), p.687-688

2018

Volltextzugriff (PDF)

Comparative Study of Prostatic Transuretral Resection Versus Prostatic Photovaporization with Green Light XPS 180W Laser in the Treatment of the Benign Prostatic Hyperplasia: Cost-Effectiveness Analysis

Value in health, 2018-09, Vol.21, p.S114

2018

Volltextzugriff (PDF)

PUK9 - Comparative Study of Prostatic Transuretral Resection Versus Prostatic Photovaporization with Green Light XPS 180W Laser in the Treatment of the Benign Prostatic Hyperplasia: Cost-Effectiveness Analysis

Value in health, 2018-09, Vol.21, p.S114-S114

2018

Volltextzugriff (PDF)

PDB25 - Real World Data Analysis of Type 2 Diabetes Mellitus Treatment In An Integrated Health District

Value in health, 2017-10, Vol.20 (9), p.A478-A478

2017

Volltextzugriff (PDF)

IMPACT OF CARDIOVASCULAR DRUG ON ALL-CAUSE MORTALITY IN SECONDARY PREVENTION. A POPULATION STUDY

Journal of hypertension, 2018-06, Vol.36 (Supplement 1), p.e42-e43

2018

Volltextzugriff (PDF)

[LB.01.13] THE USE OF CARDIOVASCULAR PREVENTIVE DRUGS IN SUBJECTS AFTER MYOCARDIAL INFARCTION. A POPULATION BASED STUDY

Journal of hypertension, 2017-09, Vol.35 (Supplement 2), p.e164

2017

Volltextzugriff (PDF)

Multimorbidity Pharmaceutical Cost of Diabetes Mellitus

Value in health, 2014-11, Vol.17 (7), p.A341-A342

2014

Volltextzugriff (PDF)

POSB401 Economic Impact of Innovative Drugs for Multiple Sclerosis: A Real-World Data Analysis

Value in health, 2022-01, Vol.25 (1), p.S259-S259

2022

Volltextzugriff (PDF)

Trends in multidrug-resistant tuberculosis

The journal of venomous animals and toxins including tropical diseases, 2008, Vol.14 (2), p.203-223

2008

Volltextzugriff (PDF)

Economic Impact of Drugs De-Funding and Pharmaceutical Co-Payment

Value in health, 2014-11, Vol.17 (7), p.A415-A415

2014

Volltextzugriff (PDF)

Predisposing, reinforcing, and enabling factors influencing influenza vaccination acceptance among healthcare workers

Infection control and hospital epidemiology, 2006-01, Vol.27 (1), p.73

2006

Volltextzugriff (PDF)

PNS268 Prediction of TOTAL and Ambulatory Prescription Cost Based on Health State Using a Machine Learning Approach

Value in health, 2020-12, Vol.23, p.S686-S686

2020

Volltextzugriff (PDF)

PHP50 Ambulatory Pharmaceutical Spending Analysis Based on Risk Stratification in Patients with Chronic Conditions

Value in health, 2012-11, Vol.15 (7), p.A297-A297

2012

Volltextzugriff (PDF)

Pharmaceutical Cost Analysis of Diabetes Mellitus Using Clinical Risk Groups in Valencian Community

Value in health, 2013-11, Vol.16 (7), p.A691-A691

2013

Volltextzugriff (PDF)

Explaining primary healthcare pharmacy expenditure using classification of medications for chronic conditions

Health policy (Amsterdam), 2011-11, Vol.103 (1), p.9-15

2011

Volltextzugriff (PDF)

Trends in multidrug-resistant tuberculosis

The journal of venomous animals and toxins including tropical diseases, 2008, Vol.14 (2), p.203-223

2008

Volltextzugriff (PDF)

PHP45 Predictability of Pharmaceutical Spending Using Clinical Risk Groups in the Valencian Community in Valencia

Value in health, 2011, Vol.14 (7), p.A341-A341

2011

Volltextzugriff (PDF)

PDB96 - APPLYING MCDA FRAMEWORK IN PHARMACEUTICAL POLICY DECISION MAKING: A PILOT STUDY IN DIABETES MELLITUS TYPE 2

Value in health, 2018-10, Vol.21, p.S135-S135

2018

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(81)
Mit Volltextzugriff
(82)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Humans
(20)
Life Sciences & Biomedicine
(20)
Female
(12)
Male
(10)
Adult
(7)
Internal Medicine
(7)
Middle Aged
(7)
Pharmacology & Pharmacy
(6)
Biological And Medical Sciences
(5)
Hematology, Oncology And Palliative Medicine
(5)
Medical Sciences
(5)
Microbiology
(4)
Surgery
(4)
Age Factors
(3)
General & Internal Medicine
(3)
Immunocompromised Host
(3)
Patients
(3)
Prospective Studies
(3)
Risk Factors
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Development and implementation of an immunotherapy unit in a urology department

Real World Data Analysis of Type 2 Diabetes Mellitus Treatment In An Integrated Health District

Textbook Outcome in Oncological Pancreatic Surgery. Systematic Review of the Literature

EPIDEMIOLOGY OF HYPERTENSION IN AN URBAN AREA DEPENDING OF A TERTIARY HOSPITAL

IMPACT ON MORTALITY OF THE GAP IN THE USE OF CARDIOVASCULAR PREVENTING DRUGS IN DIABETES: A POPULATION STUDY

[LB.03.12] THE USE OF CARDIOVASCULAR PREVENTION DRUGS IN SUBJECTS AFTER STROKE OR TIA. A POPULATION STUDY

Desarrollo e implementación de una unidad de inmunoterapia en un servicio de urología

Niveles de complejidad asistencial en pacientes con códigos diagnósticos de insuficiencia cardiaca en una población

Comparative Study of Prostatic Transuretral Resection Versus Prostatic Photovaporization with Green Light XPS 180W Laser in the Treatment of the Benign Prostatic Hyperplasia: Cost-Effectiveness Analysis

PUK9 - Comparative Study of Prostatic Transuretral Resection Versus Prostatic Photovaporization with Green Light XPS 180W Laser in the Treatment of the Benign Prostatic Hyperplasia: Cost-Effectiveness Analysis

PDB25 - Real World Data Analysis of Type 2 Diabetes Mellitus Treatment In An Integrated Health District

IMPACT OF CARDIOVASCULAR DRUG ON ALL-CAUSE MORTALITY IN SECONDARY PREVENTION. A POPULATION STUDY

[LB.01.13] THE USE OF CARDIOVASCULAR PREVENTIVE DRUGS IN SUBJECTS AFTER MYOCARDIAL INFARCTION. A POPULATION BASED STUDY

Multimorbidity Pharmaceutical Cost of Diabetes Mellitus

POSB401 Economic Impact of Innovative Drugs for Multiple Sclerosis: A Real-World Data Analysis

Trends in multidrug-resistant tuberculosis

Economic Impact of Drugs De-Funding and Pharmaceutical Co-Payment

Predisposing, reinforcing, and enabling factors influencing influenza vaccination acceptance among healthcare workers

PNS268 Prediction of TOTAL and Ambulatory Prescription Cost Based on Health State Using a Machine Learning Approach

PHP50 Ambulatory Pharmaceutical Spending Analysis Based on Risk Stratification in Patients with Chronic Conditions

Pharmaceutical Cost Analysis of Diabetes Mellitus Using Clinical Risk Groups in Valencian Community

Explaining primary healthcare pharmacy expenditure using classification of medications for chronic conditions

Trends in multidrug-resistant tuberculosis

PHP45 Predictability of Pharmaceutical Spending Using Clinical Risk Groups in the Valencian Community in Valencia

PDB96 - APPLYING MCDA FRAMEWORK IN PHARMACEUTICAL POLICY DECISION MAKING: A PILOT STUDY IN DIABETES MELLITUS TYPE 2

Suchergebnisse filtern